Is HeraMED Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, HeraMED Ltd (HMD.AX) is currently classified as NOT HALAL as of February 2024. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is HeraMED Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes HeraMED Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of HeraMED Ltd?

Muslim investors may consider investing in HeraMED Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is HeraMED Ltd classified as NOT HALAL?

Musaffa determines the Shariah status of HeraMED Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for HeraMED Ltd updated?

The Shariah compliance status of HeraMED Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like HeraMED Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of HeraMED Ltd?

You can check the latest Shariah compliance status of HeraMED Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

HMD.AX Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: February 17, 2024

Report Source: 2023 2nd Quarter Report

HeraMED Ltd. Stock Analysis HMD.AX

Australia Health Care Nano Cap Report: Q2, 2023

HeraMED Ltd. engages in the development and production of pregnancy monitoring solutions for home and professional use. The company is headquartered in Perth, Western Australia. The company went IPO on 2018-12-12. The firm is engaged in the digital transformation of maternity care by transforming the prenatal and postpartum experience with its hybrid maternity care platform. The firm offers a proprietary platform that utilizes hardware and software to reshape the doctor/patient relationship using its clinically validated in-home fetal and maternal heart rate monitor, HeraBEAT, cloud computing, artificial intelligence, and big data. The HeraBEAT medical device is used by pregnant women in Europe, the United States, Israel and Australia. The Company’s proprietary offering, HeraCARE, is engineered to offer a fully integrated maternal health ecosystem designed to deliver care to ensure expectant mothers are engaged, informed and well-supported, allowing healthcare professionals to provide quality care and enable early detection and prevention of potential risks.

Key Statistics of HeraMED Ltd (HMD.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.04AUD0.04

Today's Open

AUD0.04

Volume

50.00K

P/E Ratio (TTM)

52 Week Range

AUD0.01AUD0.06

Market Cap

57.75M

Avg. Volume

314.92K

Dividend Yield

Financial Metrics & Statements of HeraMED Ltd (HMD.AX)

FAQ's for HeraMED Ltd (HMD.AX)

According to Musaffa’s Shariah screening methodology, HeraMED Ltd (HMD.AX) is currently classified as NOT HALAL as of February 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.